Beam Therapeutics stock price
빔 테라퓨틱스NASDAQ:BEAM · Nasdaq · Healthcare$24.50+0.45%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Beam Therapeutics last closed at $24.50 (+0.45%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -29.9×. Its overall grade ranks 334 of 739 stocks in Healthcare.
About this company
Beam Therapeutics last closed at $24.50 (+0.45%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B · 334/739
Valuation grade A-
Related stocks
- Vertex PharmaceuticalsCompetitor
유전자 편집·희귀질환 치료제 개발에서 직접 경쟁
- Intellia TherapeuticsCompetitor
CRISPR 기반 유전자 편집 치료제 개발 경쟁사
- Editas MedicineCompetitor
유전자 편집 플랫폼 및 치료제 파이프라인 경쟁
About Beam Therapeutics
- What technical signals does Beam Therapeutics (BEAM) have?
- Beam Therapeutics current technical signals: no active technical signal.
- Is Beam Therapeutics a cup-and-handle pattern?
- No. Beam Therapeutics has no valid Cup signal right now.
- What published figures are available for Beam Therapeutics?
- Market cap: $2.49B. Trailing 12 months PER: -29.9×. Latest quarter PBR: 2.39×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Beam Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy